HK95194A - Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine - Google Patents

Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine

Info

Publication number
HK95194A
HK95194A HK95194A HK95194A HK95194A HK 95194 A HK95194 A HK 95194A HK 95194 A HK95194 A HK 95194A HK 95194 A HK95194 A HK 95194A HK 95194 A HK95194 A HK 95194A
Authority
HK
Hong Kong
Prior art keywords
aids
htlv
vaccine
antibodies
diagnosis
Prior art date
Application number
HK95194A
Other languages
English (en)
Inventor
James Jian Guang Wang
Chang Yi Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/847,102 external-priority patent/US4735896A/en
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of HK95194A publication Critical patent/HK95194A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK95194A 1985-09-11 1994-09-08 Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine HK95194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77464485A 1985-09-11 1985-09-11
US83756686A 1986-03-04 1986-03-04
US06/847,102 US4735896A (en) 1986-03-04 1986-04-02 Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions

Publications (1)

Publication Number Publication Date
HK95194A true HK95194A (en) 1994-09-16

Family

ID=27419712

Family Applications (1)

Application Number Title Priority Date Filing Date
HK95194A HK95194A (en) 1985-09-11 1994-09-08 Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine

Country Status (9)

Country Link
EP (1) EP0214709B1 (es)
JP (1) JP2702911B2 (es)
AU (1) AU579467B2 (es)
DE (2) DE214709T1 (es)
DK (1) DK198086A (es)
ES (1) ES8801839A1 (es)
HK (1) HK95194A (es)
IL (1) IL78696A (es)
NO (1) NO176798C (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
AU7234387A (en) * 1986-03-24 1987-10-20 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US4943627A (en) * 1986-06-12 1990-07-24 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
FR2610632B1 (fr) * 1987-02-11 1990-12-21 Pasteur Institut Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
CA1341436C (en) * 1987-03-25 2003-08-05 Wesley L. Cosand Synthetic antigens for the detection of aids-related disease caused by lav-2
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
US5854400A (en) * 1987-05-29 1998-12-29 Tanox, Inc. Monoclonal antibodies which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US5149623A (en) * 1988-02-09 1992-09-22 Virotest, Inc. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DK0489968T3 (da) * 1990-12-14 1997-03-24 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
CA2567813C (en) 2004-05-23 2015-11-24 Gerard M. Housey Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN102146116B (zh) * 2010-12-30 2013-02-13 桂林医学院 罗汉果甜苷v特异性抗血清的制备及检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
US5063150A (en) * 1984-09-19 1991-11-05 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease

Also Published As

Publication number Publication date
JP2702911B2 (ja) 1998-01-26
EP0214709A3 (en) 1988-09-21
AU5680386A (en) 1987-04-16
NO861697L (no) 1987-03-12
NO176798B (no) 1995-02-20
ES554592A0 (es) 1988-02-16
JPS6261996A (ja) 1987-03-18
DK198086D0 (da) 1986-04-30
DE3689097T2 (de) 1994-04-21
IL78696A (en) 1991-04-15
DE214709T1 (de) 1987-10-15
IL78696A0 (en) 1986-08-31
DK198086A (da) 1987-03-12
EP0214709A2 (en) 1987-03-18
DE3689097D1 (de) 1993-11-04
AU579467B2 (en) 1988-11-24
NO176798C (no) 1995-05-31
ES8801839A1 (es) 1988-02-16
EP0214709B1 (en) 1993-09-29

Similar Documents

Publication Publication Date Title
HK95194A (en) Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine
EP0261224A4 (en) SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE.
ZA853025B (en) Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins
EP0229622A3 (en) Process for the preparation of 2-oxo-1,3-dioxolanes
LTIP1793A (en) Method for detecting antibodies against hiv virus
AR242201A1 (es) Procedimiento para la preparacion de 2-oxo-1,3-dioxolanos.
NO166522C (no) Fremgangsmaate for aa forbedre den mekaniske styrke av et finerark.
DE3779831D1 (de) Vorrichtung zum befestigen von einem paar kleiderverschlusselementen.
ZA882658B (en) Method for detecting antibodies to human immunodeficiency virus
AU562944B2 (en) Snap-fit clasp fastener for bags
RO81505A (ro) Procedeu pentru prepararea unor amide ale acidului 1,2,3-triazolocarboxilic
SG83694G (en) Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine.
FR2607703B1 (fr) Polypeptides a action immunologique, leur procede de preparation, et leur utilisation pour la preparation de vaccins antipaludeens et de trousses de diagnostic pour la detection d'anticorps antisporozoaires
FR2607808B1 (fr) Procede de preparation de trifluoromethylbenzonitrile a partir de trifluoromethylbenzaldehyde
FR2601035B1 (fr) Procede de preparation de l-lysine
GR870567B (en) Process for the preparation of a tripeptide with immunostimulating activity
PT85033A (en) Process for the preparation of novel peptides
LTIP1597A (en) N,n-disubstituted beta-aminopropionic acids
MW5888A1 (en) Method for detecting antibodies to human immunodeficiency virus
ZA882095B (en) Synthetic peptide antigens for the detection of hiv-1 infection
RO91514A2 (ro) Procedeu de preparare a n-(2,6-diclorfenil)-2-indolinonei
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
ATE95190T1 (de) Synthetisches peptid und verfahren fuer dessen benutzung zum nachweis von antikoerpern zu htlviii, diagnose von aids und pre-aids-bedingungen und als impfstoffe.
RO95050A2 (ro) Procedeu pentru prepararea unor alcanoilanilide
IL82467A0 (en) 3-alkoxy-3-pyrrolin-2-on-1-ylacetic acid amides,process for the preparation thereof and the use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)